Declining Epstein-Barr Virus Antibody Prevalence in College Freshmen Strengthens the Rationale for a Prophylactic EBV Vaccine

Background: To better understand the epidemiology of primary Epstein-Barr virus (EBV) infection and to identify EBV-naïve candidates eligible to receive a prophylactic EBV vaccine, we screened freshmen from the University of Minnesota Class of 2025 for circulating EBV antibody, which is indicative o...

Descripción completa

Detalles Bibliográficos
Autores principales: Balfour, Henry H., Meirhaeghe, Madeline R., Stancari, Arianna L., Geris, Jennifer M., Condon, Lawrence M., Cederberg, Laurel E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505200/
https://www.ncbi.nlm.nih.gov/pubmed/36146477
http://dx.doi.org/10.3390/vaccines10091399

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505200/
https://www.ncbi.nlm.nih.gov/pubmed/36146477
http://dx.doi.org/10.3390/vaccines10091399

Ejemplares similares